According to Merck's latest financial reports the company's current earnings (TTM) are $17.77 B. In 2021 the company made an earning of $15.16 B an increase over its 2020 earnings that were of $9.62 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $17.77 B | 17.25% |
2021 | $15.16 B | 57.55% |
2020 | $9.62 B | -22.12% |
2019 | $12.35 B | 30.45% |
2018 | $9.47 B | 30.2% |
2017 | $7.27 B | 35.93% |
2016 | $5.35 B | -11.87% |
2015 | $6.07 B | -66.29% |
2014 | $18.01 B | 183.88% |
2013 | $6.34 B | -33.02% |
2012 | $9.47 B | 17.21% |
2011 | $8.08 B | 241.23% |
2010 | $2.36 B | -84.96% |
2009 | $15.74 B | 158.81% |
2008 | $6.08 B | 8.33% |
2007 | $5.61 B | 52.38% |
2006 | $3.68 B | -37.08% |
2005 | $5.85 B | -11.4% |
2004 | $6.61 B | -25.02% |
2003 | $8.81 B | -8.78% |
2002 | $9.66 B | -0.62% |
2001 | $9.72 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $23.03 B | 29.60% | ๐บ๐ธ USA |
![]() Novartis NVS | $23.58 B | 32.66% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $34.92 B | 96.46% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $9.31 B | -47.61% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $6.54 B | -63.15% | ๐บ๐ธ USA |
![]() Amgen AMGN | $7.72 B | -56.52% | ๐บ๐ธ USA |
![]() Sanofi SNY | $8.65 B | -51.32% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $7.71 B | -56.62% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $6.58 B | -62.96% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -$1.34 B | -107.50% | ๐ฎ๐ฑ Israel |